Ulain Qurat, Han Lu, Wu Qian, Zhao Lanbo, Wang Qi, Tuo Xiaoqian, Wang Yiran, Wang Qing, Ma Sijia, Sun Chao, Song Qing, Li Qiling
1 Department of Obstetrics and Gynecology, First Affiliated Hospital, Xi'an Jiaotong University, Xi'an Shaanxi, China.
2 Department of Epidemiology, Health Science Center, Xi'an Jiaotong University, Xi'an Shaanxi, China.
J Int Med Res. 2018 Dec;46(12):4885-4897. doi: 10.1177/0300060518803041. Epub 2018 Oct 25.
The effectiveness of indocyanine green (ICG) dye for detecting sentinel lymph nodes (SLNs) in cervical cancer compared with other tracers is unknown. This study aimed to assess the validity of ICG dye in detecting SLNs in cervical cancer preoperatively.
We performed a literature search for identifying eligible articles from PubMed database using the search terms "cervical cancer", "sentinel lymph node", "indocyanine green", "blue dyes", "human serum albumin", and "technetium-99 radiocolloid". We performed a meta-analysis. Comparison of the overall, bilateral, and unilateral detection rates of the different tracers was the primary goal. Comparison of the false-negative rate among the tracers was the secondary goal.
Only eight retrospective studies including 661 patients were included. ICG versus combinations of three other tracers showed significantly higher bilateral and unilateral detection rates, but no difference in the overall rate of detecting SLNs. ICG had a higher bilateral detection rate than blue dye and technetium-99. Absorbing human serum albumin into ICG as a lymphatic tracer did not show a difference in detection rate compared with ICG alone.
ICG is superior and better than other tracers, and absorbing human serum albumin as a lymphatic tracer is not required in patients with cervical cancer.
与其他示踪剂相比,吲哚菁绿(ICG)染料在检测宫颈癌前哨淋巴结(SLN)方面的有效性尚不清楚。本研究旨在评估ICG染料在术前检测宫颈癌SLN中的有效性。
我们使用“宫颈癌”“前哨淋巴结”“吲哚菁绿”“蓝色染料”“人血清白蛋白”和“锝-99放射性胶体”等检索词在PubMed数据库中进行文献检索,以识别符合条件的文章。我们进行了一项荟萃分析。主要目标是比较不同示踪剂的总体、双侧和单侧检测率。次要目标是比较示踪剂之间的假阴性率。
仅纳入了八项回顾性研究,共661例患者。ICG与其他三种示踪剂组合相比,双侧和单侧检测率显著更高,但在检测SLN的总体率上没有差异。ICG的双侧检测率高于蓝色染料和锝-99。将人血清白蛋白加入ICG作为淋巴示踪剂与单独使用ICG相比,检测率没有差异。
ICG优于其他示踪剂,宫颈癌患者无需将人血清白蛋白作为淋巴示踪剂。